Cannabidiol-Based Prodrugs: Synthesis and Bioevaluation.
Sign Up to like & getrecommendations! Published in 2024 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.3c00461
Abstract: Cannabidiol (CBD 1) is a nonpsychotic cannabinoid-based drug approved by the U.S. FDA for treating refractory epilepsy, namely, Lennox-Gastaut and Dravet syndrome. However, its low aqueous solubility and oral bioavailability are compensated by administering high… read more here.
Keywords: synthesis bioevaluation; cannabidiol based; cbd based; based prodrugs ... See more keywords